Adipocytes are endocrine cells that function as the main energy storage in our body. They are commonly used in clinical procedures, including their removal via liposuction and transplantation in plastic surgery. Building on this, adipocytes can be used for ex vivo cellular manipulations, enabling therapeutic modifications that can provide beneficial clinical outcomes after transplantation. Here, we provide a detailed protocol on how to modify adipocytes and adipose organoids using CRISPR activation (CRISPRa), a technology termed adipose manipulation transplantation (AMT). Key features ⢠This protocol is used to generate adipocytes and adipose organoids from human preadipocytes that can be genetically engineered for therapeutic purposes, including cancer metabolic therapy.
Reprogramming White Fat Cells for Adipose Manipulation Transplantation (AMT) Therapy.
对白色脂肪细胞进行重编程以用于脂肪组织操作移植(AMT)疗法
阅读:5
作者:An Kelly, Ito Yusuke, Ahituv Nadav
| 期刊: | Bio-protocol | 影响因子: | 1.100 |
| 时间: | 2025 | 起止号: | 2025 Aug 5; 15(15):e5405 |
| doi: | 10.21769/BioProtoc.5405 | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
